4.3 Article

Poly-Omic Prediction of Complex Traits: OmicKriging

期刊

GENETIC EPIDEMIOLOGY
卷 38, 期 5, 页码 402-415

出版社

WILEY
DOI: 10.1002/gepi.21808

关键词

complex trait prediction; polygenic modeling; systems biology; polygenic prediction; Kriging

资金

  1. Pharmacogenomics and Risk of Cardiovascular Disease (PARC) [U19 HL069757-11]
  2. NHLBI
  3. Wellcome Trust [076113, 085475]
  4. Pharmacogenetics of Anticancer Agents Research (PAAR) Group [UO1GM61393]
  5. Genotype-Tissue Expression project (GTeX) [R01 MH101820, R01 MH090937]
  6. University of Chicago DRTC(Diabetes Research and Training Center [P60 DK20595, P30 DK020595]
  7. University of Chicago Cancer Center [NCI P30 CA014599-36]
  8. PGRN Statistical Analysis Resource [U19 HL065962]
  9. Conte Center [P50MH094267]
  10. National Research Service [F32CA165823]
  11. National Cancer Institute [K12CA139160]

向作者/读者索取更多资源

High-confidence prediction of complex traits such as disease risk or drug response is an ultimate goal of personalized medicine. Although genome-wide association studies have discovered thousands of well-replicated polymorphisms associated with a broad spectrum of complex traits, the combined predictive power of these associations for any given trait is generally too low to be of clinical relevance. We propose a novel systems approach to complex trait prediction, which leverages and integrates similarity in genetic, transcriptomic, or other omics-level data. We translate the omic similarity into phenotypic similarity using a method called Kriging, commonly used in geostatistics and machine learning. Our method called OmicKriging emphasizes the use of a wide variety of systems-level data, such as those increasingly made available by comprehensive surveys of the genome, transcriptome, and epigenome, for complex trait prediction. Furthermore, our OmicKriging framework allows easy integration of prior information on the function of subsets of omics-level data from heterogeneous sources without the sometimes heavy computational burden of Bayesian approaches. Using seven disease datasets from the Wellcome Trust Case Control Consortium (WTCCC), we show that OmicKriging allows simple integration of sparse and highly polygenic components yielding comparable performance at a fraction of the computing time of a recently published Bayesian sparse linear mixed model method. Using a cellular growth phenotype, we show that integrating mRNA and microRNA expression data substantially increases performance over either dataset alone. Using clinical statin response, we show improved prediction over existing methods. We provide an R package to implement OmicKriging (http://www.scandb.org/newinterface/tools/OmicKriging.html). Genet Epidemiol 38: 402-415, 2014. (C) 2014 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据